HCA Healthcare, Inc. 2024 Annual Report (10-K) Summary
Business Context and Reporting Period
This summary covers the fiscal year ended December 31, 2024. HCA Healthcare, Inc. is a leading U.S. health care services company operating 190 hospitals (180 general acute care, 6 behavioral, 4 rehabilitation), 124 freestanding ambulatory surgery centers, and 26 freestanding endoscopy centers across 20 U.S. states and England. The company's strategy focuses on operational excellence, physician recruitment, and expanding comprehensive service networks.
Key Financial Metrics
| Metric | 2024 | 2023 | Change |
|---|---|---|---|
| Revenues | $70.603 billion | $64.968 billion | +8.7% |
| Net Income (Attributable to HCA) | $5.760 billion | $5.242 billion | +9.9% |
| Diluted EPS | $22.00 | $18.97 | +16.0% |
| Operating Cash Flow | $10.514 billion | $9.431 billion | +11.5% |
| Total Debt | $43.031 billion | $39.593 billion | +8.7% |
| Interest Expense | $2.061 billion | $1.938 billion | +6.3% |
| Capital Expenditures | $4.875 billion | $4.744 billion | +2.8% |
| Share Repurchases | $6.042 billion | $3.811 billion | +58.5% |
| Dividends Paid | $690 million | $661 million | +4.4% |
Operating Margins: Salaries and benefits were 44.1% of revenues (down from 45.4% in 2023). Supplies were 15.2% of revenues (flat). Other operating expenses were 21.0% of revenues (up from 19.8%).
Material Changes vs. Prior Period
- Volume Growth: Consolidated admissions increased 5.0% and equivalent admissions (inpatient + outpatient) increased 5.3%. Inpatient surgeries rose 2.2%, while outpatient surgeries declined 1.9%.
- Revenue Drivers: Revenue growth was driven by a 5.3% increase in equivalent admissions and a 3.2% increase in revenue per equivalent admission.
- Uncompensated Care: The estimated cost of total uncompensated care increased to $4.366 billion (from $3.720 billion in 2023), driven by a 13.8% increase in uninsured emergency room visits.
- Disaster Impact: Results included approximately $250 million in additional expenses and revenue losses related to Hurricanes Helene and Milton impacting facilities in North Carolina and Florida.
- Debt Activity: The company issued $7.5 billion in new senior notes during 2024 to repay revolving credit facilities and fund general corporate purposes, while repaying $2.0 billion in maturing notes.
Guidance, Outlook, and Risks
Management Commentary: Management expects capital expenditures to approximate $5.0 billion to $5.2 billion in 2025. The company continues to face inflationary pressures on operating expenses, particularly labor and supply costs, though salaries and benefits as a percentage of revenue improved in 2024.
Key Risks and Contingencies:
- Regulatory & Reimbursement: Significant exposure to changes in Medicare and Medicaid reimbursement rates, including sequestration cuts and potential changes to Disproportionate Share Hospital (DSH) payments. The company faces uncertainty regarding the expiration of enhanced premium tax credits in 2025, which could increase the uninsured population.
- Indebtedness: With $43.0 billion in total debt, the company is exposed to interest rate fluctuations and refinancing risks. Debt covenants restrict flexibility regarding dividends, repurchases, and additional borrowing.
- Human Capital: Ongoing competition for nurses and physicians, potential unionization activity, and rising labor costs remain critical operational risks.
- Cybersecurity: The company faces evolving threats from ransomware and data breaches, which could disrupt operations and incur significant remediation costs.
- Legal & Compliance: Subject to government investigations, False Claims Act (FCA) litigation, and professional liability claims (reserves totaled $2.131 billion at year-end).
Investor Verification Checklist
- Debt Service Coverage: Verify the ability to service $43 billion in debt given the $2.06 billion interest expense and potential for rising rates on variable portions.
- Uncompensated Care Trends: Monitor the trajectory of uninsured ER visits and the associated $4.4 billion cost, as this directly impacts net revenue.
- Medicaid Policy Changes: Assess the impact of potential federal funding reductions or state-level changes to Medicaid expansion and supplemental payment programs, which contributed $4.9 billion to 2024 revenues.
- Capital Allocation: Review the sustainability of the $6.0 billion share repurchase program alongside $5.0 billion+ in planned capital expenditures.
- Professional Liability Reserves: Track the $2.13 billion reserve for professional liability risks and the $627 million provision for losses, noting the sensitivity to claim frequency and severity trends.